Literature DB >> 19706226

Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis.

Brian Chan1, Brigette Hales, Neil Shear, Vincent Ho, Charles Lynde, Yves Poulin, Nicole Mittmann.   

Abstract

BACKGROUND: Psoriasis impacts many different areas of a patient's life, including work productivity. There is no information regarding lost productivity owing to psoriasis in a Canadian population.
OBJECTIVE: The objective of this study was to determine the lost productivity of Canadian patients with moderate to severe psoriasis.
METHODS: Seventy-nine consecutive Canadian dermatology patients were interviewed and completed the Work Productivity and Activity Impairment Questionnaire (WPAIQ).
RESULTS: On average, 2.2 hours (+/- 5.6 hours) were lost from work per week owing to psoriasis-related events. Absence from work may result in lost mean patient wages of C$2,270.84 per person per year. Total lost wages owing to moderate to severe psoriasis may cost up to approximately $749 million for all moderate to severe psoriasis patients in Canada.
CONCLUSION: The results from our study indicate that moderate to severe psoriasis may have a substantial impact on the work productivity of patients with this disease.

Entities:  

Mesh:

Year:  2009        PMID: 19706226     DOI: 10.2310/7750.2009.08068

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  9 in total

1.  Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study.

Authors:  Javaria Mona Khalid; Gary Globe; Kathleen M Fox; Dina Chau; Andrew Maguire; Chio-Fang Chiou
Journal:  BMC Dermatol       Date:  2013-08-19

Review 2.  Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.

Authors:  Philip J Mease; April W Armstrong
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

3.  How much of the productivity losses among psoriasis patients are due to psoriasis.

Authors:  Anssi Mustonen; Kalle Mattila; Mauri Leino; Leena Koulu; Risto Tuominen
Journal:  BMC Health Serv Res       Date:  2015-03-04       Impact factor: 2.655

Review 4.  Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective.

Authors:  Lorenzo Mantovani; Massimo Medaglia; Patrizio Piacentini; Marcella Tricca; Gino Antonio Vena; Antonietta Vozza; Gabriella Castellino; Alessandro Roccia
Journal:  Dermatol Ther (Heidelb)       Date:  2016-04-15

Review 5.  The effects of autoimmune blistering diseases on work productivity: A review.

Authors:  Esther Q Wang; M Adriana Castrillón Velásquez; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2018-02-09

6.  Cost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia.

Authors:  Nor Azmaniza Azizam; Aniza Ismail; Saperi Sulong; Norazirah Md Nor
Journal:  Int J Health Policy Manag       Date:  2019-07-01

7.  Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil.

Authors:  Nilcéia Lopes; Leticia L S Dias; Luna Azulay-Abulafia; Luiza K M Oyafuso; Maria Victoria Suarez; Lincoln Fabricio; Clarice Marie Kobata; Tania Cestari; Bernardo Gontijo; Cid Y Sabbag; João R Antonio; Ricardo Romiti; Patricia C Pertel
Journal:  Adv Ther       Date:  2019-08-20       Impact factor: 3.845

8.  Nail psoriasis as a severity indicator: results from the PsoReal study.

Authors:  Marc A Radtke; Anna K Langenbruch; Ines Schäfer; Katharina Herberger; Kristian Reich; Matthias Augustin
Journal:  Patient Relat Outcome Meas       Date:  2010-12-22

9.  The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: a cross-sectional study.

Authors:  Sungwon Jung; Seung-Mi Lee; David Suh; Hyun Taek Shin; Dong-Churl Suh
Journal:  Health Qual Life Outcomes       Date:  2018-09-12       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.